Literature DB >> 24136671

Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012.

Emily R Perito1, Sue Rhee, John Paul Roberts, Philip Rosenthal.   

Abstract

Decision making concerning liver transplantation is unique for children with urea cycle disorders (UCDs) and organic acidemias (OAs) because of their immediate high priority on the waiting list, which is not related to the severity of their disease. There are limited national outcome data on which recommendations about liver transplantation for UCDs or OAs can be based. This study was a retrospective analysis of United Network for Organ Sharing data for liver recipients who underwent transplantation at an age < 18 years in 2002-2012. Repeat transplants were excluded. Among the pediatric liver transplants, 5.4% were liver-only for UCDs/OAs. The proportion of transplants for UCDs/OAs increased from 4.3% in 2002-2005 to 7.4% in 2010-2012 (P < 0.001). Ninety-six percent were deceased donor transplants, and 59% of these patients underwent transplantation at <2 years of age. Graft survival improved as the age at transplant increased (P = 0.04). Within 5 years after transplantation, the graft survival rate was 78% for children < 2 years old at transplant and 88% for children ≥ 2 years old at transplant (P = 0.06). Vascular thrombosis caused 44% of the graft losses, and 65% of these losses occurred in children < 2 years old. Patient survival also improved as the age at transplant increased: the 5-year patient survival rate was 88% for children with UCDs/OAs who were <2 years old at transplant and 99% for children who were ≥2 years old at transplant (P = 0.006). At the last-follow-up (54 ± 34.4 months), children who underwent transplantation for UCDs/OAs were more likely to have cognitive and motor delays than children who underwent transplantation for other indications. Cognitive and motor delays for children with UCDs/OAs were associated with metabolic disorders, but they were not predicted by age or weight at transplant, sex, ethnicity, liver graft type (split versus whole), or hospitalization at transplant in univariate and multivariate analyses. In conclusion, most liver transplants for UCDs/OAs occur in early childhood. Further research on the benefits of early transplantation for patients with UCDs/OAs is needed because a younger age may increase posttransplant morbidity.
© 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 24136671      PMCID: PMC3877181          DOI: 10.1002/lt.23765

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  19 in total

1.  Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.

Authors:  Sue McDiarmid; Robert G Gish; Simon Horslen; George V Mazariegos
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

2.  An ethical and policy analysis of elective transplantation for metabolic conditions diagnosed by newborn screening.

Authors:  Lainie Friedman Ross
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

3.  Living donor liver transplantation for pediatric patients with inheritable metabolic disorders.

Authors:  Daisuke Morioka; Mureo Kasahara; Yasutsugu Takada; Jose Pablo Garbanzo Corrales; Atsushi Yoshizawa; Seisuke Sakamoto; Kaoru Taira; Elena Yukie Yoshitoshi; Hiroto Egawa; Hiroshi Shimada; Koichi Tanaka
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

4.  Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors.

Authors:  Daisuke Morioka; Yasutsugu Takada; Mureo Kasahara; Takashi Ito; Kenji Uryuhara; Kohei Ogawa; Hiroto Egawa; Koichi Tanaka
Journal:  Transplantation       Date:  2005-09-15       Impact factor: 4.939

5.  Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.

Authors:  Philippe M Campeau; Penelope J Pivalizza; Geoffrey Miller; Kim McBride; Saul Karpen; John Goss; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2010-02-19       Impact factor: 4.797

6.  Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience.

Authors:  Ronen Arnon; Nanda Kerkar; Michael K Davis; Ravinder Anand; Wanrong Yin; Regino P González-Peralta
Journal:  Pediatr Transplant       Date:  2010-06-27

7.  Liver transplantation in children with metabolic disorders in the United States.

Authors:  Liise K Kayler; Cynthia S Rasmussen; Dawn M Dykstra; Jeffrey D Punch; Steven M Rudich; John C Magee; Martin A Maraschio; Juan D Arenas; Darrell A Campbell; Robert M Merion
Journal:  Am J Transplant       Date:  2003-03       Impact factor: 8.086

Review 8.  Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.

Authors:  Daisuke Morioka; Mureo Kasahara; Yasutsugu Takada; Yasumasa Shirouzu; Kaoru Taira; Seisuke Sakamoto; Kenji Uryuhara; Hiroto Egawa; Hiroshi Shimada; Koichi Tanaka
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

Review 9.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

10.  Liver transplantation for the treatment of urea cycle disorders.

Authors:  P F Whitington; E M Alonso; J T Boyle; J P Molleston; P Rosenthal; J C Emond; J M Millis
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

View more
  14 in total

Review 1.  Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review.

Authors:  Francesco Giuseppe Foschi; Maria Cristina Morelli; Sara Savini; Anna Chiara Dall'Aglio; Arianna Lanzi; Matteo Cescon; Giorgio Ercolani; Alessandro Cucchetti; Antonio Daniele Pinna; Giuseppe Francesco Stefanini
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 2.  Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Authors:  Sandra Sirrs; Fady Hannah-Shmouni; Stephen Nantel; James Neuberger; Eric M Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-02-01       Impact factor: 4.982

Review 3.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

4.  Impaired Health-Related Quality of Life in Children and Families Affected by Methylmalonic Acidemia.

Authors:  Kimberly Splinter; Anna-Kaisa Niemi; Rachel Cox; Julia Platt; Monisha Shah; Gregory M Enns; Mureo Kasahara; Jonathan A Bernstein
Journal:  J Genet Couns       Date:  2015-12-14       Impact factor: 2.537

5.  Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.

Authors:  Susan E Waisbren; Andrea L Gropman; Mark L Batshaw
Journal:  J Inherit Metab Dis       Date:  2016-05-23       Impact factor: 4.982

6.  Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time.

Authors:  Ioannis A Ziogas; W Kelly Wu; Lea K Matsuoka; Anita K Pai; Einar T Hafberg; Lynette A Gillis; Thomas M Morgan; Sophoclis P Alexopoulos
Journal:  Liver Transpl       Date:  2021-08-01       Impact factor: 6.112

7.  Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).

Authors:  Alexander Laemmle; Renata C Gallagher; Adrian Keogh; Tamar Stricker; Matthias Gautschi; Jean-Marc Nuoffer; Matthias R Baumgartner; Johannes Häberle
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

Review 8.  Treating inborn errors of liver metabolism with stem cells: current clinical development.

Authors:  Etienne Marc Sokal
Journal:  J Inherit Metab Dis       Date:  2014-03-26       Impact factor: 4.982

9.  Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia.

Authors:  Noha Elserafy; Sue Thompson; Troy Dalkeith; Michael Stormon; Gordon Thomas; Albert Shun; Janine Sawyer; Shanti Balasubramanian; Kaustuv Bhattacharya; Nadia Badawi; Carolyn Ellaway
Journal:  JIMD Rep       Date:  2021-05-04

10.  Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data.

Authors:  Femke Molema; Diego Martinelli; Friederike Hörster; Stefan Kölker; Trine Tangeraas; Barbara de Koning; Carlo Dionisi-Vici; Monique Williams
Journal:  J Inherit Metab Dis       Date:  2020-10-29       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.